Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne's
muscular dystrophy
(DMD) locus. Utrophin is of therapeutic interest since its over-expression can compensate dystrophin's absence. Utrophin is enriched at neuromuscular junctions due to heregulin-mediated utrophin-A promoter activation. We demonstrate that heregulin activated
MSK1
/2 and phosphorylated histone H3 at serine 10 in cultured C2C12 muscle cells, in an ERK-dependent manner.
MSK1
/2 inhibition suppressed heregulin-mediated utrophin-A activation.
MSK1
over-expression potentiated heregulin-mediated utrophin-A activation and chromatin remodeling at the utrophin-A promoter. These results identify
MSK1
/2 as key effectors modulating utrophin-A expression as well as identify novel targets for DMD therapy.
...
PMID:Heregulin-induced epigenetic regulation of the utrophin-A promoter. 1769 45